HSK44459

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Efficacy and SafetyAtopic DermatitisPsoriasisARTIdiopathic Pulmonary Fibrosis

228 competitors in Efficacy and Safety

#DrugCompanyPhaseTrials

1

Kineret

SSwedish Orphan Biovitrum

Phase 3

22

Tegoprazan

SShandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Phase 3

43

PLB1004

AAvistone Biotechnology Co., Ltd.

Phase 3

14

S1,

CChinese Academy of Medical Sciences

Phase 3

15

Tpoxx

SSIGA Technologies

Phase 3

16

Hemay005

GGanzhou Hemay Pharmaceutical Co., Ltd

Phase 3

27

Rhtpo

SShandong University

Phase 3

18

HSK44459

Haisco Pharmaceutical Group Co., Ltd.

Phase 2

19

KN057

SSuzhou Alphamab Co., Ltd.

Phase 3

210

IN-B00009

HHK inno.N Corporation

Phase 3

1Show 34 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Idiopathic Pulmonary Fibrosis2 trials

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Not yet recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT06764862·120 enrolled

Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Not yet recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT07019090·120 enrolled

Psoriasis1 trial

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Not yet recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT07150988·150 enrolled

Atopic Dermatitis1 trial

A Study for HSK44459 in Participants With Atopic Dermatitis

Active, not recruiting·XXizang Haisco Pharmaceutical Co., Ltd·Phase 2·NCT06996912·150 enrolled

ESS1 trial

A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects

Completed·Haisco Pharmaceutical Group Co., Ltd.·Phase 1·NCT06858657·82 enrolled

Efficacy and Safety1 trial

Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease

Not yet recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT06902428·120 enrolled

1 more indication

ART1 trial

A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease

Not yet recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT07070739·120 enrolled

Details

Drug Info

Related News